THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,226 | -98.6% | 15,901 | -98.4% | 0.00% | -100.0% |
| Q2 2023 | $9,985,928 | -73.2% | 964,824 | -71.9% | 0.00% | -50.0% |
| Q1 2023 | $37,202,242 | +34.1% | 3,428,778 | +38.6% | 0.00% | -33.3% |
| Q4 2022 | $27,752,356 | +7.7% | 2,473,472 | -2.6% | 0.00% | 0.0% |
| Q3 2022 | $25,759,000 | +5.4% | 2,540,287 | -5.9% | 0.00% | +50.0% |
| Q2 2022 | $24,447,000 | -5.1% | 2,698,350 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $25,763,000 | -9.9% | 2,694,912 | +4.1% | 0.00% | 0.0% |
| Q4 2021 | $28,601,000 | +44.7% | 2,588,381 | -3.1% | 0.00% | 0.0% |
| Q3 2021 | $19,764,000 | -87.4% | 2,670,881 | -75.3% | 0.00% | -83.3% |
| Q2 2021 | $156,698,000 | -21.1% | 10,791,863 | +10.9% | 0.01% | -29.4% |
| Q1 2021 | $198,592,000 | +17.1% | 9,730,166 | +2.0% | 0.02% | +13.3% |
| Q4 2020 | $169,557,000 | +21.1% | 9,541,794 | +0.7% | 0.02% | +7.1% |
| Q3 2020 | $140,038,000 | -29.1% | 9,471,622 | +0.7% | 0.01% | -36.4% |
| Q2 2020 | $197,464,000 | -8.8% | 9,407,530 | +0.4% | 0.02% | -26.7% |
| Q1 2020 | $216,436,000 | -1.2% | 9,365,444 | +10.7% | 0.03% | +25.0% |
| Q4 2019 | $218,994,000 | +34.6% | 8,458,657 | +1.3% | 0.02% | +20.0% |
| Q3 2019 | $162,702,000 | +20.4% | 8,352,274 | +0.9% | 0.02% | +25.0% |
| Q2 2019 | $135,169,000 | -27.2% | 8,277,295 | +1.0% | 0.02% | -27.3% |
| Q1 2019 | $185,782,000 | -11.1% | 8,195,049 | +0.3% | 0.02% | -24.1% |
| Q4 2018 | $209,065,000 | -21.2% | 8,169,815 | +0.6% | 0.03% | -3.3% |
| Q3 2018 | $265,403,000 | +44.8% | 8,123,744 | +0.5% | 0.03% | +42.9% |
| Q2 2018 | $183,288,000 | -6.4% | 8,081,504 | +0.1% | 0.02% | -8.7% |
| Q1 2018 | $195,771,000 | -11.7% | 8,073,011 | +1.5% | 0.02% | -11.5% |
| Q4 2017 | $221,822,000 | -18.0% | 7,953,484 | +0.6% | 0.03% | -21.2% |
| Q3 2017 | $270,664,000 | -13.4% | 7,904,898 | +0.8% | 0.03% | -15.4% |
| Q2 2017 | $312,555,000 | +24.0% | 7,845,253 | +14.6% | 0.04% | +21.9% |
| Q1 2017 | $252,012,000 | +42.0% | 6,844,430 | +22.9% | 0.03% | +33.3% |
| Q4 2016 | $177,496,000 | +21.5% | 5,567,636 | +38.1% | 0.02% | +26.3% |
| Q3 2016 | $146,059,000 | +96.4% | 4,030,326 | +22.9% | 0.02% | +90.0% |
| Q2 2016 | $74,383,000 | +106.1% | 3,278,215 | +70.8% | 0.01% | +100.0% |
| Q1 2016 | $36,083,000 | +22.5% | 1,919,303 | +6.8% | 0.01% | +25.0% |
| Q4 2015 | $29,450,000 | +2089.6% | 1,796,810 | +1367.8% | 0.00% | – |
| Q3 2015 | $1,345,000 | +362.2% | 122,419 | +447.2% | 0.00% | – |
| Q2 2015 | $291,000 | -31.7% | 22,370 | -9.0% | 0.00% | – |
| Q1 2015 | $426,000 | +16.1% | 24,570 | 0.0% | 0.00% | – |
| Q4 2014 | $367,000 | -94.7% | 24,570 | -91.8% | 0.00% | -100.0% |
| Q3 2014 | $6,891,000 | -59.4% | 298,948 | -43.9% | 0.00% | -50.0% |
| Q2 2014 | $16,982,000 | – | 532,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |